NMRA – neumora therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Neumora Therapeutics Inc (NMRA) Sheds More Light on Phase 1b Study of NMRA-511 [Yahoo! Finance]
Neumora Therapeutics (NASDAQ:NMRA) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.
Neumora Therapeutics to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026
Neumora Therapeutics (NASDAQ:NMRA) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Neumora Therapeutics (NASDAQ:NMRA) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $8.00 price target on the stock.
Form 4 Neumora Therapeutics, For: Feb 17 Filed by: Aurora Daljit Singh
Form 4 Neumora Therapeutics, For: Feb 17 Filed by: Pinto Joshua
Form 4 Neumora Therapeutics, For: Feb 17 Filed by: BERNS PAUL L
Form 4 Neumora Therapeutics, For: Feb 17 Filed by: Milligan Michael Lee
Form SCHEDULE 13G Neumora Therapeutics, Filed by: Invus Global Management, LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.